Publicaciones indexadas de acceso libre sobre nutrición clínica especializada, organizadas por línea de producto. Seleccionadas por nuestro equipo científico.
De Luis DA, Izaola O, De la Fuente B, Muñoz-Calero P, Franco-Lopez A.
Las enfermedades neurodegenerativas producen alteraciones en el nivel de conciencia o en los mecanismos de la deglución que frecuentemente obligan a un soporte nutricional especializado. Revisión del riesgo de desnutrición y su tratamiento en pacientes con enfermedad cerebral vascular, Parkinson, demencia y esclerosis lateral amiotrófica.
Portero Tresserra M, Pineda Hernández S.
Las enfermedades neurodegenerativas son enfermedades crónicas que tienden a generar una gran discapacidad física, intelectual y social. Existe una estrecha relación entre las enfermedades neurológicas y la nutrición. Aborda epidemiología, factores de riesgo, nutrigenómica, alimentación neuroprotectora (dieta mediterránea, polifenoles, antioxidantes) y recomendaciones nutricionales para el tratamiento.
Jane E. Kerstetter,* Jessica D. Bihuniak,* Jennifer Brindisi, Rebecca R. Sullivan, Kelsey M. Mangano, Sarah Larocque, Belinda M. Kotler, Christine A. Simpson, Anna Maria Cusano, Erin Gaffney-Stomberg, Alison Kleppinger, Jesse Reynolds, James Dziura, Anne M. Kenny,* and Karl L. Insogna*
Context: It has been assumed that the increase in urine calcium (Ca) that accompanies an increase in dietary protein was due to increased bone resorption. However, studies using stable Ca isotopes have found that dietary protein increases Ca absorption without increasing bone resorption. Objective: The objective of the study was to investigate the impact of a moderately high protein diet on bone mineral density (BMD). Design: This was a randomized, double-blind, placebo-controlled trial of protein supplementation daily for 18 months. Setting: The study was conducted at two institutional research centers. Participants: Two hundred eight older women and men with a body mass index between 19 and 32 kg/m2 and a self-reported protein intake between 0.6 and 1.0 g/kg participated in the study. Intervention: Subjects were asked to incorporate either a 45-g whey protein or isocaloric maltodextrin supplement into their usual diet for 18 months. Main Outcome Measure: BMD by dual-energy x-ray absorptiometry, body composition, and markers of skeletal and mineral metabolism were measured at baseline and at 9 and 18 months. Results: There werenosignificant differences between groups for changes in L-spineBMD(primary outcome) or the other skeletal sites of interest. Truncal lean mass was significantly higher in the protein group at 18 months (P .048). C-terminal telopeptide (P .0414), IGF-1 (P .0054), and urinary urea (P.001) were also higher in the protein group at the end of the study period. There was no difference in estimated glomerular filtration rate at 18 months.